Product development and Clinical studies

Karessa works with substances that have already been approved for use as medicinal products in previous products. Since the development is based on a proven substance, previous documentation can be used, which results in a significantly shorter time to market, lower costs and reduced development risks.

Clinical studies

Karessa's strategy is to carry out its own PK studies to verify pre-clinical data for each project Karessa may be outlicensing the projects after dose/PK-data studies and, if so, collaborate with partner/licentiate in the pivotal clinical study.